Startseite/News/Press Releases/TIF Supports Administration Of COVID-19 Vaccine Booster Dose To Patients With Haemoglobin Disorders Press ReleasesTIF News (DE)News TIF Supports Administration Of COVID-19 Vaccine Booster Dose To Patients With Haemoglobin Disorders Weniger als eine Minute 211020_ TIF Announcement_COVID-19 Vaccine Boosters SchlagwörterCOVID-19 Pandemic Vulnerable COVID-19 Vaccines AtRisk Thalassaemia Haemoglobin Disorders Vaccinations COVID-19 TIF News #news Sickle cell Healthcare Professionals Patients Weniger als eine Minute Facebook Twitter LinkedIn Teile per E-Mail Drucken
